Nanotechnology-Enhanced Vaccines: New inulin bioconjugates to defeat global pandemic threats. Inulin-based adjuvants have the potential to revolutionise the vaccine arena; man's critical first line of defence against infectious disease. Any breakthrough in developing completely safe new adjuvants, will therefore be of major global significance, and will play a vital role in the maintenance of global health for decades. New and completely safe vaccine adjuvants are a vital step in the developmen ....Nanotechnology-Enhanced Vaccines: New inulin bioconjugates to defeat global pandemic threats. Inulin-based adjuvants have the potential to revolutionise the vaccine arena; man's critical first line of defence against infectious disease. Any breakthrough in developing completely safe new adjuvants, will therefore be of major global significance, and will play a vital role in the maintenance of global health for decades. New and completely safe vaccine adjuvants are a vital step in the development of improved vaccine technology in the 21st century. This project addresses two National Research Priorities, Namely Promoting and Maintaining Good Health and Safeguarding Australia. On commercialization, this will then be an important Australian contribution towards protecting the nation against any future pandemic outbreaks.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0453832
Funder
Australian Research Council
Funding Amount
$550,910.00
Summary
New directions in biomolecular mass spectrometry. The combined UoW/ANU mass spectrometry facility supports a range of research projects in high priority areas including proteomics, mechanisms of aging, anticancer drugs and pathogenicity. The facility has several key deficiencies: 1) the ability to study very high molecular weight biomolecular complexes, 2) the ability to study ion-molecule interactions that have implications in mechanisms of chemistry in nature, and 3) researchers at ANU lack es ....New directions in biomolecular mass spectrometry. The combined UoW/ANU mass spectrometry facility supports a range of research projects in high priority areas including proteomics, mechanisms of aging, anticancer drugs and pathogenicity. The facility has several key deficiencies: 1) the ability to study very high molecular weight biomolecular complexes, 2) the ability to study ion-molecule interactions that have implications in mechanisms of chemistry in nature, and 3) researchers at ANU lack essential walk-up access to high sensitivity protein sequence analysis (MS/MS). The placement of resources that address these deficiencies in one geographical region and collaboration between these institutions will produce a research interaction unique in Australia.Read moreRead less